期刊文献+

宁夏地区新生儿先天性肾上腺皮质增生症筛查切值确立初探 被引量:3

Preliminary study on screening of neonatal congenital adrenal hyperplasia in Ningxia
下载PDF
导出
摘要 目的了解宁夏地区新生儿17-羟孕桐(17-OHP)水平与不同胎龄、体重的关系,制定适宜切值,减少假阳性。方法对宁夏新生儿疾病筛查中心采集并筛查的有完整信息的185 748例新生儿17-OHP水平的筛查结果用百分位数法进行分析,以P99确定切值。结果相对于体重,新生儿孕周与17-OHP水平相关性最大,并呈负相关性,故应增设早产儿相应的切值。结论在宁夏地区新生儿先天性肾上腺皮质增生症(CAH)筛查中,足月儿与早产儿的17-OHP应采取不同切值,足月儿(≥37周)17-OHP初筛值建议设为30.0 nmol/L,早产儿(<37周)初筛值建议设为57.0 nmol/L。 Objective To understand the relationship between 17 -OHP levels and gestational age,body weight of neonatus in Ningxia in order to establish appropriate cut value and reduce false positive rate. Methods 185748 cases of neonatal screening in Ningx- ia neonatal screening center with complete information collection and 17 - OHP level were analyzed by percentile method and determine the cut - off value of P99. Results Compared to body weight, the correlation between gestational week and 17 - OHP level was the most significant and negative correlation. Conclusions In the neonatal CAH screening in the Ningxia, 17 - OHP value of full term infants and premature infants should be different, 17 - OHP screening recommended value is 30.0nmol/L in full - term infants ( ≥ 37 w). The screening recommended value is set to 57.0 nmol/L in preterm infants( 〈 37 w) .
出处 《宁夏医学杂志》 CAS 2017年第12期1128-1130,共3页 Ningxia Medical Journal
基金 宁夏卫计委重点科研计划项目(NW2015054)
关键词 新生儿 胎龄 肾上腺皮质增生症 17-羟孕桐 Neonate Gestational age CAH 17 - OHP
  • 相关文献

参考文献8

二级参考文献77

  • 1罗小平,祝婕.先天性肾上腺皮质增生症的诊断及治疗[J].实用儿科临床杂志,2006,21(8):510-512. 被引量:42
  • 2曹敏.先天性肾上腺皮质增生症的临床若干问题[J].浙江临床医学,2006,8(7):673-674. 被引量:3
  • 3郭辉,闵娟,毛维玉,林琳华,吴本清,何林.出生后采血时间对新生儿CAH筛查结果的影响分析[J].国际医药卫生导报,2007,13(10):34-36. 被引量:4
  • 4吴圣嵋,陈惠金,朱建幸,等.新生儿医学[M].上海:上海科学技术出版社,2006:1001-1002.
  • 5Shinagawa T,Horikawa R,Isojima T,et al.Nonclassic steroid 21-hydroxylase deficiency due to a homozygous V281L mutation in CYP21A2 detected by the neonatal mass-screening program in Japan[J].Endocr J,2007,54(6):1021-1025.
  • 6Huynh T,Mc Gown I,Cowley D,et al.The clinical and biochemical spectrum of congenital adrenal hyperplasia secondary to 21-hydroxylase deficiency[J].Clin Biochem,2009,30(2):75-86.
  • 7Hayashi G,Faure C,Brondi MF,et al.Weight-adjusted neonatal 17OH-progesterone cutoff levels improve the efficiency of newborn screening for congenital adrenal hyperplasia[J].Arq Bras Endocrinol Metabol,2011,55(8):632-637.
  • 8Vander Kamp HJ,Oudshoorn CG,Elvers BH,et al.Cutoff levels of 17-alpha-hydroxyprogesterone in neonatal screening for congenital adrenal hyperplasia should be based on gestational age rather than on birth weight[J].J Clin Endocrinol Metab,2005,90(7):3904-3907.
  • 9Van der Kamp HJ,Wit JM.Neonatal screening for congeni-tal adrenal hyperplasia[J].Eur J Endocrinol,2004,151(Suppl3):U71.
  • 10Olgemller B,Roscher AA,Liebl B,et al.Screening for con-genital adrenal hyperplasia:adjustment of17-hydroxyprogester-one cut-off values to both age and birth weight markedly im-proves the predictive value[J].J Clin Endocrinol Metab,2003,88(12):5790.

共引文献45

同被引文献35

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部